Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell‐free DNA aneuploidy screening

11 Aug 2015

Abstract excerpt

In late 2012, a new screening test for fetal aneuploidy based on circulating cell-free DNA (cfDNA) became available to Australian women. The introduction of this technology in the United States has led to a reduction in invasive diagnostic procedures. Analysis of the number of amniocentesis and chorionic villus sampling (CVS) procedures performed in Australia from 1994 to 2014 shows that the introduction of cfDNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics
Share to Tumors and Oncological Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26259499
DOI: 10.1111/ajo.12380

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell‐free DNA aneuploidy screeningPMID 26259499Read ↗

Population‐based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state‐wide dataSemantic proximity Read ↗

ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practiceSemantic proximity Read ↗

A decade of non‐invasive prenatal screening in Australia: National impact on prenatal screening and diagnostic testingSemantic proximity Read ↗

Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and GenomicsSemantic proximity Read ↗

ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practiceSemantic proximity Read ↗

Clinical implementation of cell‐free <scp>DNA</scp>‐based aneuploidy screening: perspectives from a national auditSemantic proximity Read ↗

Reappraisal of evolving methods in non-invasive prenatal screening: Discovery, biology and clinical utilitySemantic proximity Read ↗

Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US contextSemantic proximity Read ↗

Position statement from the International Society for Prenatal Diagnosis on the use of non‐invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnanciesSemantic proximity Read ↗

Population‐based trends in the prenatal diagnosis of sex chromosome aneuploidy before and after non‐invasive prenatal testingSemantic proximity Read ↗

NSGC Practice Guideline: Prenatal Screening and Diagnostic Testing Options for Chromosome AneuploidySemantic proximity Read ↗

Amniocentesis and chorionic villus samplingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.